Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL - PubMed (original) (raw)
. 2002 Jun 27;417(6892):975-8.
doi: 10.1038/nature00767. Epub 2002 Jun 5.
Affiliations
- PMID: 12050673
- DOI: 10.1038/nature00767
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL
Wai-Ching Hon et al. Nature. 2002.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability. HIF-1 alpha is the oxygen-regulated subunit of HIF-1, an alpha beta heterodimeric complex. HIF-1 alpha is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degradation by the ubiquitination complex pVHL, the protein of the von Hippel Lindau (VHL) tumour suppressor gene and a component of an E3 ubiquitin ligase complex. Capture of HIF-1 alpha by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1 alpha. The crystal structure of a hydroxylated HIF-1 alpha peptide bound to VCB (pVHL, elongins C and B) and solution binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL. Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues. This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.
Similar articles
- Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling.
Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP. Min JH, et al. Science. 2002 Jun 7;296(5574):1886-9. doi: 10.1126/science.1073440. Epub 2002 May 9. Science. 2002. PMID: 12004076 - Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Jaakkola P, et al. Science. 2001 Apr 20;292(5516):468-72. doi: 10.1126/science.1059796. Epub 2001 Apr 5. Science. 2001. PMID: 11292861 - Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
Mole DR, Maxwell PH, Pugh CW, Ratcliffe PJ. Mole DR, et al. IUBMB Life. 2001 Jul;52(1-2):43-7. doi: 10.1080/15216540252774757. IUBMB Life. 2001. PMID: 11795592 Review. - Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex.
Miller F, Kentsis A, Osman R, Pan ZQ. Miller F, et al. J Biol Chem. 2005 Mar 4;280(9):7985-96. doi: 10.1074/jbc.M413160200. Epub 2004 Dec 20. J Biol Chem. 2005. PMID: 15611064 - Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
Maynard MA, Ohh M. Maynard MA, et al. Am J Nephrol. 2004 Jan-Feb;24(1):1-13. doi: 10.1159/000075346. Epub 2003 Dec 3. Am J Nephrol. 2004. PMID: 14654728 Review.
Cited by
- Targeted protein degradation: advances in drug discovery and clinical practice.
Zhong G, Chang X, Xie W, Zhou X. Zhong G, et al. Signal Transduct Target Ther. 2024 Nov 6;9(1):308. doi: 10.1038/s41392-024-02004-x. Signal Transduct Target Ther. 2024. PMID: 39500878 Free PMC article. Review. - Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design.
Qiu Y, Wiewiora RP, Izaguirre JA, Xu H, Sherman W, Tang W, Huang X. Qiu Y, et al. JACS Au. 2024 Sep 24;4(10):3857-3868. doi: 10.1021/jacsau.4c00503. eCollection 2024 Oct 28. JACS Au. 2024. PMID: 39483225 Free PMC article. - Human prolyl hydroxylase domain 2 reacts with O2 and 2-oxoglutarate to enable formation of inactive Fe(III).2OG.hypoxia-inducible-factor α complexes.
Fiorini G, Marshall SA, Figg WD Jr, Myers WK, Brewitz L, Schofield CJ. Fiorini G, et al. Sci Rep. 2024 Oct 30;14(1):26162. doi: 10.1038/s41598-024-75761-y. Sci Rep. 2024. PMID: 39478091 Free PMC article. - Genotype-phenotype correlation of ocular von Hippel-Lindau disease in Koreans.
Hwang S, Kang SW, Kim JW, Kim SJ. Hwang S, et al. PLoS One. 2024 Oct 7;19(10):e0311665. doi: 10.1371/journal.pone.0311665. eCollection 2024. PLoS One. 2024. PMID: 39374255 Free PMC article. - Molecular chaperones: Guardians of tumor suppressor stability and function.
Heritz JA, Backe SJ, Mollapour M. Heritz JA, et al. Oncotarget. 2024 Oct 1;15:679-696. doi: 10.18632/oncotarget.28653. Oncotarget. 2024. PMID: 39352796 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases